HomeNewsBusinessCoronavirus impact: Broking firms mull permanent shift to work from home for most staff to cut cost

Coronavirus impact: Broking firms mull permanent shift to work from home for most staff to cut cost

The work-from-home concept adopted during the 21-day lockdown period may alter the format of the broking sector forever.

April 14, 2020 / 16:02 IST
Story continues below Advertisement

The novel coronavirus pandemic and the resultant nationwide lockdown and financial woes may prompt the Indian equity broking industry to adopt the work-from-home concept permanently, at least for a significant number of its workforce, experts say.

The work-from-home structure adopted during the 21-day lockdown period may alter the format of the broking sector forever as the cash-strapped industry is looking for cues to slash cost without actually cutting manpower.

Story continues below Advertisement

Says Rajendra Bhambhani, Joint Managing Director of Philip Capital, who deals mainly with foreign institutional investors: "We are analysing the changing dynamics of the functioning of our company now. We might allow some departments to work from home 3 to 4 days a week. We can even call people to the office on a rotational basis. Departments like back-office or sales could work from home".

In fact, some surveys have shown that a significant number of the global workforce who have been forced to work from home because of the COVID-19 pandemic may find themselves permanently working from home. According to brokers, around 20-25 percent of the workforce could be allowed to work from home in the Indian context.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show